Company Quick10K Filing
Vegalab
10-Q 2018-06-30 Filed 2018-08-30
10-Q 2018-03-31 Filed 2018-07-13
10-K 2017-12-31 Filed 2018-06-04
10-Q 2017-09-30 Filed 2017-11-17
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-07-21
10-K 2016-12-31 Filed 2017-07-21
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-03-29
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-12
10-Q 2015-03-31 Filed 2015-05-14
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-13
10-K 2012-12-31 Filed 2013-03-12
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-13
10-Q 2012-03-31 Filed 2012-05-08
10-K 2011-12-31 Filed 2012-03-15
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-12
10-K 2010-12-31 Filed 2011-03-01
10-Q 2010-09-30 Filed 2010-10-28
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-17
8-K 2019-07-17
8-K 2019-01-31
8-K 2018-11-08
8-K 2018-09-07
8-K 2018-08-28
8-K 2018-08-14
8-K 2018-02-20
8-K 2017-12-29

Vegalab Financials

VEGL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Cell Medx (CMXC) 5,757 -6.5 -472% 191 1,963 0 0 -899 -882 5,700
Easterly Acquisition (EACQ) 68,264 22.5 2% 146,697 10,863 0 0 3,039 3,039 68,262
Poage Bankshares (PBSK) 68,196 17.6 -1% 440,728 379,510 0 0 -2,208 2,582 45,344
Omnicomm Systems (OMCM) 67,280 81% -19.4 -44% 11,253 24,136 19,457 15,843 -4,922 -3,707 71,940
Prime Meridian Holding (PMHG) 66,178 0% -3.7 1% 484,066 429,039 142 0 2,595 4,868 -18,100
Helix TCS (HLIX) 65,696 44% -12.3 -12% 74,083 7,816 11,011 4,865 -8,865 -5,311 65,477
Yatra (TRTL) 65,640 -20.6 -3% 99,561 6,580 0 0 -3,178 -3,178 65,500
Vegalab (VEGL) 65,417 14% -32.6 -22% 10,374 4,714 11,635 1,671 -2,270 -2,012 65,545
Integrity Applications (IGAP) 64,825 0% -72.7 -44% 1,974 2,836 140 0 -874 -874 63,546
Radisys (RSYS) 64,574 27% -97.1 -33% 57,835 65,385 109,918 29,205 -19,359 -578 56,127
Peoples Financial (PFBX) 64,261 11.4 0% 617,489 523,162 0 0 553 3,135 35,782
Electrum Special Acquisition (ELECU) 64,124 -356.8 -0% 128,485 11,837 0 0 -180 -180 64,096
Summer Energy (SUME) 63,005 9% -19.8 -9% 60,900 51,472 130,021 11,888 -5,619 -3,470 68,685
Sonim Technologies (SONM) 62,906 32% -3.4 -28% 68,973 40,342 99,081 31,437 -19,057 -16,692 56,855
Cryo Cell (CCEL) 62,661 68% 27.7 1% 40,889 48,983 23,494 15,913 575 2,439 67,644
I-On Communications (ALES) 62,354 20% -80.0 -13% 8,863 2,470 5,283 1,043 -1,111 -758 60,670
Nephros (NEPH) 62,276 58% -14.8 -38% 11,554 4,832 8,942 5,182 -4,384 -4,006 59,300
Kaanapali Land (KANP) 62,158 7% -9.8 -3% 106,294 24,515 4,885 364 -2,988 -3,678 36,038
Imprimis Pharmaceuticals (IMMY) 62,078 77% -27.3 -14% 28,289 23,836 29,988 23,163 -4,097 -2,510 68,431
INmune Bio (INMB) 61,884 -10.2 -21% 25,396 687 0 0 -5,360 -5,360 54,502

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-30
Cash000000001050134200789046225039126130343647222
Accounts Receivable220007461706717327377151,6751,834964
Inventory7046882,3321,8891,9651,9021,4721,5951,5283,659
PP&E19231,0211,1041,239
Assets4210320022606361153808071,4852,7442,5962,7772,8212,3684,7879,54410,374
Accounts Payable22223333121222221515193332668105631114099881,628
Long-Term Debt429350350
Liabilities525459626770747784891211221572502462502572444378032,0981,9902,1662,0491,6262,4382,8934,714
Stockholders' Equity-44-52-58-62-65-68-74-77-82-87-115-122151-214-235-245-254-1653696836456066117727422,3496,6515,660
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-30
Revenue0000000000000001,4331555282091671807,2894,166
Cost of Revenue1,0521044611891211675,6964,457
Gross Profit38150671946133561,593-290
R&D8
SG&A222201222232591432545754922594952231,1561,642717
Tax00000000000000000650-48000000
Net Income-4-4-5-5-2-4-6-3-5-4-29-7102-193-22-9-9-11-49193-37-224-225-254-210-985-57-1,018
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-30
Cash Operating-2-2-4-4-2-2-2-5-5-16-565-145-32-3-2-22-362-1634-225-160-175-949501-284
Cash Investing00000000000000-550-196-138
Cash Financing224422254220239101210037312017501992731,711-1-2